09.25.19
Research published in Food Research International showed the spore-forming probiotic GanedenBC30 may help relieve gastrointestinal symptoms (GI) and upper respiratory tract infection symptoms (URTI) in children.
The study found that supplementation with GanedenBC30 significantly reduced the incidence of flatulence and suggested a positive effect on stool consistency. In addition, the probiotic significantly decreased the incidence of URTI symptoms, including nasal congestion, bloody nasal mucus, itchy nose and hoarseness, and the duration of hoarseness, headache, red eyes, and fatigue.
Eighty healthy school-aged children in Mexico took part in this randomized, double-blind, placebo-controlled study. They received a flavored water containing either GanedenBC30 (1 billion CFU) or a placebo, daily for 12 weeks.
“While there is already a large body of evidence for the digestive and immune health benefits of GanedenBC30, this research is particularly exciting because it is the first to focus on children, and shows the enormous potential of GanedenBC30 as a functional ingredient in products for kids,” said Don Cox, research and development director for Kerry’s ProActive Health Division, the makers of GanedenBC30.
Study data indicated GanedenBC30 may have the ability to modulate the immune response, based on beneficial effects on URTI and GI symptoms. Previous studies have shown that GanedenBC30 can reduce gastrointestinal symptoms in adults with post-prandial intestinal gas-related symptoms, and improves pain and bloating in irritable bowel syndrome (IBS) sufferers.
“We are committed to driving forward probiotic innovation through science and helping meet the demand for high-quality ingredients, substantiated by high-quality research,” Cox said. “These latest findings support our ongoing efforts to provide an efficacious probiotic ingredient that can withstand harsh manufacturing processes and conditions in the body.”
The study found that supplementation with GanedenBC30 significantly reduced the incidence of flatulence and suggested a positive effect on stool consistency. In addition, the probiotic significantly decreased the incidence of URTI symptoms, including nasal congestion, bloody nasal mucus, itchy nose and hoarseness, and the duration of hoarseness, headache, red eyes, and fatigue.
Eighty healthy school-aged children in Mexico took part in this randomized, double-blind, placebo-controlled study. They received a flavored water containing either GanedenBC30 (1 billion CFU) or a placebo, daily for 12 weeks.
“While there is already a large body of evidence for the digestive and immune health benefits of GanedenBC30, this research is particularly exciting because it is the first to focus on children, and shows the enormous potential of GanedenBC30 as a functional ingredient in products for kids,” said Don Cox, research and development director for Kerry’s ProActive Health Division, the makers of GanedenBC30.
Study data indicated GanedenBC30 may have the ability to modulate the immune response, based on beneficial effects on URTI and GI symptoms. Previous studies have shown that GanedenBC30 can reduce gastrointestinal symptoms in adults with post-prandial intestinal gas-related symptoms, and improves pain and bloating in irritable bowel syndrome (IBS) sufferers.
“We are committed to driving forward probiotic innovation through science and helping meet the demand for high-quality ingredients, substantiated by high-quality research,” Cox said. “These latest findings support our ongoing efforts to provide an efficacious probiotic ingredient that can withstand harsh manufacturing processes and conditions in the body.”
